{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T00:51:29Z","timestamp":1789865489098,"version":"4.0.1"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1097\/mph.0000000000000391","type":"journal-article","created":{"date-parts":[[2015,7,11]],"date-time":"2015-07-11T21:30:55Z","timestamp":1436650255000},"page":"e433-e434","source":"Crossref","is-referenced-by-count":10,"title":["Neurological Complications and Cataract in a Child With Thalassemia Major Treated With Deferiprone"],"prefix":"10.1097","volume":"37","author":[{"given":"Nupur","family":"Parakh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajni","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Om","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DeoNath","family":"Mahto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavna","family":"Dhingra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvasini","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagdish","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-32-20210209","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(00)02357-6","article-title":"Survival in beta-thalassaemia major in the UK: data from the UK Thalassaemia Register.","volume":"355","author":"Modell","year":"2000","journal-title":"Lancet"},{"key":"R2-32-20210209","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s12185-009-0432-0","article-title":"1, Lee-Lee C, Chong QT, et al.. Iron chelation therapy in the management of thalassemia: the Asian perspectives.","volume":"90","author":"Viprakasit","year":"2009","journal-title":"Int J Hematol"},{"key":"R3-32-20210209","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bcmd.2009.01.002","article-title":". Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies.","volume":"42","author":"Maggio","year":"2009","journal-title":"Blood Cells Mol Dis"},{"key":"R4-32-20210209","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1182\/blood-2002-10-3280","article-title":". Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone.","volume":"102","author":"Cohen","year":"2003","journal-title":"Blood"},{"key":"R5-32-20210209","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood-2002-06-1867","article-title":"Role of deferiprone in chelation therapy for transfusional iron overload.","volume":"102","author":"Hoffbrand","year":"2003","journal-title":"Blood"},{"key":"R6-32-20210209","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1196\/annals.1345.017","article-title":"The design of orally active iron chelators.","volume":"1054","author":"Hider","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"R7-32-20210209","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2147\/JBM.S27400","article-title":". Deferiprone.","volume":"3","author":"Berdoukas","year":"2012","journal-title":"J Blood Med"},{"key":"R8-32-20210209","doi-asserted-by":"crossref","first-page":"a2319","DOI":"10.1136\/bmj.a2319","article-title":". High doses of deferiprone may be associated with cerebellar syndrome.","volume":"338","author":"Beau-Salinas","year":"2009","journal-title":"BMJ"},{"key":"R10-32-20210209","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4103\/0301-4738.60083","article-title":". Multiple transfused thalassaemic major: Ocular manifestation in a Hospital-based population.","volume":"58","author":"Taneja","year":"2010","journal-title":"Indian J Opthalmol"},{"key":"R11-32-20210209","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1444-0938.2009.00385.x","article-title":"Posterior subcapsular opacity in two patients with thalassaemia major following deferiprone consumption.","volume":"92","author":"Mehdizadeh","year":"2009","journal-title":"Clin Exp Optom"},{"key":"R12-32-20210209","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0140-6736(94)92585-2","article-title":". Arthropathy in thalassaemia patients receiving deferiprone.","volume":"343","author":"Berkovitch","year":"1994","journal-title":"Lancet"},{"key":"R13-32-20210209","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0300-483X(95)03301-U","article-title":". The pharmacokinetics and blood-brain barrier permeation of the chelators 1,2dimethly-, 1,2 diethyl-, and 1-ethan-1ol-2methyl-3-hydroxypyridin-4-one in the rat.","volume":"108","author":"Fredenburg","year":"1996","journal-title":"Toxicology"},{"key":"R14-32-20210209","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0378-4274(01)00541-0","article-title":". The influence of deferiprone (L1) and deferoxamine on iron and essential element tissue level and parameters of oxidative status in dietary iron-loaded mice.","volume":"128","author":"Eybl","year":"2002","journal-title":"Toxicol Lett"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000000391","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:47:09Z","timestamp":1620964029000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201510000-00032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":13,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000391","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}